MPRO

MPRO is an independent nonprofit and a national leader in healthcare quality improvement and medical review. MPRO also provides consultative services, medical and utilization review and data analysis to federal agencies, state Medicaid and public health agencies, healthcare facilities, private health plans and other third party payers.

Related News

TAPPING EVOLUTION TO IMPROVE BIOTECH PRODUCTS

biotech | September 26, 2016

news image

Scientists can improve protein-based drugs by reaching into the evolutionary past, a paper published in Nature Biotechnology proposes. As a proof of concept for this approach, the research team from Emory, Children's Healthcare of Atlanta and Georgia Tech showed how "ancestral sequence reconstruction" or ASR can guide engineering of the blood clotting protein known as factor VIII, which is deficient in the inherited disorder hemophilia A....

Read More

PALL LIFE SCIENCES EXTENDS THE RANGE OF CONTINUOUS, SINGLE-USE TECHNOLOGIES TO IMPROVE SPEED AND QUALITY OF BIOPHARMACEUTICAL PRODUCTION

Pall Corporation | October 04, 2016

news image

Pall Corporation, a global leader in filtration, separation and purification, is pleased to announce the launch of breakthrough technologies that for the first time enable integrated, process-scale continuous production of biotherapies in single-use formats. Biopharmaceutical manufacturers are increasingly incorporating continuous technologies to replace traditional batch methods in order to improve consistency, reduce production footprints and shorten lead times. Single-use technologies further...

Read More

EYE STUDY ADVANCES ABILITY TO IMPROVE CLINICAL MEASUREMENT OF RETINAL DEGENERATION

biotech | February 17, 2017

news image

University of Alabama at Birmingham (UAB) researchers studying rod cell proteins GARP1 and GARP2, or glutamic acid-rich proteins 1 and 2, to learn how they function in normal phototransduction in the eye have found that GARP2 accelerates retinal degeneration in mice that lack another rod cell protein, cyclic guanosine monophosphate (cGMP)-gated cation channel β-subunit, involved in producing the electrical signal....

Read More

GENETIC MODIFICATION CAN, AMONG OTHER BOONS, REDUCE FOOD WASTE AND IMPROVE THE LIVES OF DAIRY CATTLE.

biotech | March 07, 2017

news image

Despite ominous warnings from the scientific establishment that President Trump is anti-science, there is one area in which he might be more pro-science than President Obama: agriculture. Free from the constraints of hard-line, Obama-era environmentalists who opposed innovations such as genetically engineered crops, the Trump administration can energize the federal government’s sclerotic approach to green-lighting new agricultural biotechnologies. Many groundbreaking products could reduce ...

Read More
news image

TAPPING EVOLUTION TO IMPROVE BIOTECH PRODUCTS

biotech | September 26, 2016

Scientists can improve protein-based drugs by reaching into the evolutionary past, a paper published in Nature Biotechnology proposes. As a proof of concept for this approach, the research team from Emory, Children's Healthcare of Atlanta and Georgia Tech showed how "ancestral sequence reconstruction" or ASR can guide engineering of the blood clotting protein known as factor VIII, which is deficient in the inherited disorder hemophilia A....

Read More
news image

PALL LIFE SCIENCES EXTENDS THE RANGE OF CONTINUOUS, SINGLE-USE TECHNOLOGIES TO IMPROVE SPEED AND QUALITY OF BIOPHARMACEUTICAL PRODUCTION

Pall Corporation | October 04, 2016

Pall Corporation, a global leader in filtration, separation and purification, is pleased to announce the launch of breakthrough technologies that for the first time enable integrated, process-scale continuous production of biotherapies in single-use formats. Biopharmaceutical manufacturers are increasingly incorporating continuous technologies to replace traditional batch methods in order to improve consistency, reduce production footprints and shorten lead times. Single-use technologies further...

Read More
news image

EYE STUDY ADVANCES ABILITY TO IMPROVE CLINICAL MEASUREMENT OF RETINAL DEGENERATION

biotech | February 17, 2017

University of Alabama at Birmingham (UAB) researchers studying rod cell proteins GARP1 and GARP2, or glutamic acid-rich proteins 1 and 2, to learn how they function in normal phototransduction in the eye have found that GARP2 accelerates retinal degeneration in mice that lack another rod cell protein, cyclic guanosine monophosphate (cGMP)-gated cation channel β-subunit, involved in producing the electrical signal....

Read More
news image

GENETIC MODIFICATION CAN, AMONG OTHER BOONS, REDUCE FOOD WASTE AND IMPROVE THE LIVES OF DAIRY CATTLE.

biotech | March 07, 2017

Despite ominous warnings from the scientific establishment that President Trump is anti-science, there is one area in which he might be more pro-science than President Obama: agriculture. Free from the constraints of hard-line, Obama-era environmentalists who opposed innovations such as genetically engineered crops, the Trump administration can energize the federal government’s sclerotic approach to green-lighting new agricultural biotechnologies. Many groundbreaking products could reduce ...

Read More